What is seborrheic dermatitis, including its pathogenesis, clinical features, and recommended management?

Seborrheic Dermatitis: Pathogenesis, Clinical Features, and Management

Seborrheic dermatitis is a chronic inflammatory skin condition affecting sebaceous gland-rich areas (scalp, face, central chest), characterized by greasy yellowish scaling and itching, with treatment centered on topical antifungals to reduce Malassezia yeast and topical anti-inflammatory agents to control inflammation. 1

Pathogenesis

The condition results from a complex interplay of multiple factors 2:

• Malassezia yeast colonization: Secondary inflammation occurs from Malassezia species, which colonize sebaceous areas and trigger immune responses 1
• Sebaceous gland activity: Excessive sebum production in affected areas contributes to disease development 3
• Immune dysregulation: Altered immune responses to the yeast and inflammatory mediators perpetuate the condition 4
• Skin barrier dysfunction: Compromised barrier function allows microbial dysbiosis and inflammation 4

Clinical Presentation

Adults

Look for symmetric, poorly defined erythematous patches with yellow, oily scales and fine superficial flaking in sebaceous-rich areas 5:

• Distribution: Scalp, central face (eyebrows, nasolabial folds, glabella), ears, central anterior chest, and body folds 1, 5
• Scalp involvement: Ranges from mild dandruff to diffuse thick scaling 3
• Symptoms: Itching and greasy scaling are hallmark features 1

Darker Skin Tones

In patients with more richly pigmented skin, erythema may be less apparent, and postinflammatory hypopigmentation or hyperpigmentation with slightly scaly areas may be the presenting sign 5, 2

Infants

Neonatal seborrheic dermatitis ("cradle cap") presents as yellowish, scaly patches on the scalp, typically self-resolving by 6 months of age 5, 3

High-Risk Populations

Seborrheic dermatitis is more pronounced in patients with Down syndrome, HIV infection, and Parkinson's disease 1

Management Algorithm

First-Line Treatment

Scalp Involvement

Start with topical antifungal shampoos (ketoconazole, ciclopirox, miconazole) or prescription-strength antifungal/corticosteroid solutions, foams, or oils 5, 3:

• For thick, scaly areas: Add keratolytic shampoos and lotions 5
• Frequency: Apply 2-3 times weekly initially, then maintenance as needed 3

Face and Body

Use topical antifungal creams (ketoconazole, ciclopirox, clotrimazole) combined with mild-to-moderate potency corticosteroids 5, 3:

• Topical calcineurin inhibitors (tacrolimus 0.1% ointment or pimecrolimus 1% cream) are effective alternatives for facial involvement, particularly for long-term management to avoid corticosteroid side effects 1, 3
• Roflumilast 0.3% foam (topical phosphodiesterase-4 inhibitor) represents a newly approved noncorticosteroid option showing promise for effective management 4, 6

Second-Line Treatment

For severe or resistant cases 3:

• Systemic antifungals: Terbinafine or itraconazole 3
• UVB phototherapy: May be considered for recalcitrant disease 3

Infant Management

For mild "cradle cap" 5:

• Conservative approach: Mineral oil to loosen scale followed by gentle combing 5
• For more severe cases: Baby shampoos with emollient agents and vegetable oils, or medical device shampoos containing piroctone olamine, bisabolol 3
• If overlapping with atopic dermatitis: Topical antifungals or mild topical corticosteroids 5

Treatment Principles

The therapeutic strategy targets three mechanisms simultaneously 3:

1. Reduce Malassezia colonization: Topical antifungals are the cornerstone 1, 4
2. Control inflammation: Anti-inflammatory agents (corticosteroids, calcineurin inhibitors, or PDE-4 inhibitors) 1, 4
3. Normalize skin barrier and sebum production: Keratolytics and emollients 4, 3

Critical Pitfalls

• Long-term corticosteroid use: Limit treatment duration to avoid skin atrophy, telangiectasia, and tachyphylaxis 1, 4
• Distinguishing from other conditions: Seborrheic dermatitis can mimic atopic dermatitis, psoriasis, contact dermatitis, and discoid lupus—look for characteristic greasy yellow scaling in sebaceous areas to differentiate 1, 2
• Chronic relapsing nature: Patients must understand this is a chronic condition requiring ongoing maintenance therapy, not a curable disease 5, 3
• Neomycin sensitization: Avoid neomycin-containing preparations as 5-15% of patients with chronic external otitis develop allergic reactions 1